Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Long-Term Investments: 2014-2024

Historic Long-Term Investments for Surgery Partners (SGRY) over the last 10 years, with FY2024 value amounting to $215.4 million.

  • Surgery Partners' Long-Term Investments rose 679.7% to $229.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $229.4 million, marking a year-over-year increase of 679.7%. This contributed to the annual value of $215.4 million for FY2024, which is 1700.16% up from last year.
  • Latest data reveals that Surgery Partners reported Long-Term Investments of $215.4 million as of FY2024, which was up 1700.16% from $184.1 million recorded in FY2023.
  • Over the past 5 years, Surgery Partners' Long-Term Investments peaked at $215.4 million during FY2024, and registered a low of $88.7 million during FY2021.
  • For the 5-year period, Surgery Partners' Long-Term Investments averaged around $153.8 million, with its median value being $184.1 million (2023).
  • As far as peak fluctuations go, Surgery Partners' Long-Term Investments skyrocketed by 11454.34% in 2022, and later plummeted by 325.8% in 2023.
  • Annual analysis of 5 years shows Surgery Partners' Long-Term Investments stood at $90.3 million in 2020, then decreased by 1.77% to $88.7 million in 2021, then soared by 114.54% to $190.3 million in 2022, then fell by 3.26% to $184.1 million in 2023, then increased by 17.0% to $215.4 million in 2024.
  • Its last three reported values are $215.4 million in FY2024, $184.1 million for FY2023, and $190.3 million during FY2022.